Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Increasing the Awareness of the Importance of Vaccination during Pregnancy
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Capacity Building for Antimicrobial Stewardship
Release Date:
Review Process: Pfizer Internal
Education Hospital Japan
Implementation of Systemic Treatment Approaches in Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology China
Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)
Release Date:
Partner: Mayo Clinic Global Bridges Oncology
Review Process: Expert Review Panel
Translation: French (link)
Translation:(link)
Quality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe
Improving Clinical Management for Patients with Breast Cancer in China
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology China
NSCLC Cancer Precision Diagnosis and Treatment
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology China
Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism
Release Date:
Partner: BMS
Review Process: Pfizer Internal
Education Internal Medicine All
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient Settings
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Digital Education to Address Patients with COVID-19 and High Risk of Complications
Release Date:
Review Process: Pfizer Internal
Education Hospital All